Multiple Sclerosis Cladribine tablets have a rapid onset of improvements in MRI outcomes within the first year in patients with a first demyelinating event at high risk of converting to clinically ...
Chronic inflammatory demyelinating polyneuropathy is an immune-mediated neuropathy that affects the peripheral motor and sensory nerves. The symptoms are of a slowly progressive numbness and tingling ...
Nucleolar organizer region counts predict complete remission, remission duration, and survival in adult acute myelogenous leukemia patients. Twenty-four patients treated on the Medical Research ...
New York, United States, Mar 08, 2022, 10:00 /Comserve / -- Acute Disseminated Demyelination Treatment Market Company Profile; Pfizer, Inc., Johnson & Johnson Service ...
Pembrolizumab and nivolumab, two humanized antibodies against programmed cell death 1 (PD-1) receptor, were recently approved for the treatment of unresectable or metastatic melanoma and for other ...
Demyelinating diseases, including multiple sclerosis (MS) and Charcot-Marie-Tooth (CMT) disease, present a substantial and escalating burden. | Demyelinating diseases, including multiple sclerosis (MS ...
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare, acquired neurological disorder with heterogeneous presentation. It is a peripheral nerve system immune-mediated condition which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results